RxDoctor Payments Data

Kimberly White

Pediatrics · Lincoln, NENPI 1245681998

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Tris Pharma Inc at 37.1% of the total. 2025 is the largest year on record at $201, 9.3 times the $22 reported in 2019.

$690in general payments, 2019–2025

Across 30 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tris Pharma Inc$256
  • Kls-martin L.p.$76
  • Kaleo, Inc.$62
  • Sanofi-aventis U.S. LLC$46
  • Takeda Pharmaceuticals U.S.A., Inc.$38
  • Biogen$33
  • plus $178 from 10 others
$139,329in research payments, 2019–2025

Across 28 payments — averaging $4976.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$139K

What the payments were for

  • Speaking & faculty fees$223%
  • Food & beverage$66897%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$690 in reported general payments places this provider in the 70th percentile of 308 pediatrics providers in Nebraska.

See all pediatrics providers in Nebraska

Other pediatrics in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →